Home   |   Press   |   Contact   |   Sitemap   

ABETA GmbH, Heidelberg

ABETA develops diagnostic test-kits for the early detection of Alzheimer's disease. The test-kit will also be the first device for staging and therapy control of Alzheimer's patients. The company's clinical diagnostic test is based on a system already in use at the ZMBH (Centre for Molecular Biology Heidelberg) laboratories of founder Prof. Dr. Konrad Beyreuther. The first liquor-based version is in the market introduction phase and available to clinics and laboratory doctors for research purposes. An advanced version of the test shall be based on serum. In the 2nd quarter of 2003 we succeeded in selling the essential assets of ABETA to a privately-held biotech company.

Investment Manager:
- Professor Dr. Ulrich Abshagen
- Dr. Christoph Kronabel